01-04-2008
BML-111, a lipoxin receptor agonist, modulates the immune response and reduces the severity of collagen-induced arthritis
Published in: Inflammation Research | Issue 4/2008
Login to get access01-04-2008
Published in: Inflammation Research | Issue 4/2008
Login to get access